vs

Side-by-side financial comparison of GoPro, Inc. (GPRO) and Tarsus Pharmaceuticals, Inc. (TARS). Click either name above to swap in a different company.

GoPro, Inc. is the larger business by last-quarter revenue ($201.7M vs $151.7M, roughly 1.3× Tarsus Pharmaceuticals, Inc.). On growth, Tarsus Pharmaceuticals, Inc. posted the faster year-over-year revenue change (128.4% vs 0.4%). GoPro, Inc. produced more free cash flow last quarter ($15.0M vs $13.0M). Over the past eight quarters, Tarsus Pharmaceuticals, Inc.'s revenue compounded faster (134.4% CAGR vs 13.9%).

GoPro, Inc. is an American technology company founded in 2002 by Nick Woodman. It manufactures action cameras and develops its own mobile apps and video-editing software. Founded as Woodman Labs, Inc, the company is based in San Mateo, California.

Tarsus Pharmaceuticals, Inc. is a late-stage clinical biopharmaceutical company focused on developing and commercializing innovative therapeutic candidates for unmet medical needs in ophthalmology, dermatology, and other specialty care areas. It operates primarily in the United States, with lead product candidates targeting common, underdiagnosed conditions including demodex blepharitis and rosacea.

GPRO vs TARS — Head-to-Head

Bigger by revenue
GPRO
GPRO
1.3× larger
GPRO
$201.7M
$151.7M
TARS
Growing faster (revenue YoY)
TARS
TARS
+128.0% gap
TARS
128.4%
0.4%
GPRO
More free cash flow
GPRO
GPRO
$2.0M more FCF
GPRO
$15.0M
$13.0M
TARS
Faster 2-yr revenue CAGR
TARS
TARS
Annualised
TARS
134.4%
13.9%
GPRO

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
GPRO
GPRO
TARS
TARS
Revenue
$201.7M
$151.7M
Net Profit
$-8.4M
Gross Margin
31.8%
Operating Margin
-4.1%
-5.3%
Net Margin
-5.5%
Revenue YoY
0.4%
128.4%
Net Profit YoY
63.8%
EPS (diluted)
$-0.06
$-0.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GPRO
GPRO
TARS
TARS
Q4 25
$201.7M
$151.7M
Q3 25
$162.9M
$118.7M
Q2 25
$152.6M
$102.7M
Q1 25
$134.3M
$78.3M
Q4 24
$200.9M
$66.4M
Q3 24
$258.9M
$48.1M
Q2 24
$186.2M
$40.8M
Q1 24
$155.5M
$27.6M
Net Profit
GPRO
GPRO
TARS
TARS
Q4 25
$-8.4M
Q3 25
$-21.3M
$-12.6M
Q2 25
$-16.4M
$-20.3M
Q1 25
$-46.7M
$-25.1M
Q4 24
$-23.1M
Q3 24
$-8.2M
$-23.4M
Q2 24
$-47.8M
$-33.3M
Q1 24
$-339.1M
$-35.7M
Gross Margin
GPRO
GPRO
TARS
TARS
Q4 25
31.8%
Q3 25
35.1%
Q2 25
35.8%
Q1 25
32.1%
Q4 24
34.7%
Q3 24
35.5%
Q2 24
30.5%
Q1 24
34.1%
Operating Margin
GPRO
GPRO
TARS
TARS
Q4 25
-4.1%
-5.3%
Q3 25
-9.8%
-12.2%
Q2 25
-9.2%
-21.6%
Q1 25
-33.7%
-33.5%
Q4 24
-19.5%
-36.8%
Q3 24
-3.1%
-52.3%
Q2 24
-25.0%
-81.6%
Q1 24
-26.6%
-136.5%
Net Margin
GPRO
GPRO
TARS
TARS
Q4 25
-5.5%
Q3 25
-13.0%
-10.6%
Q2 25
-10.8%
-19.8%
Q1 25
-34.8%
-32.1%
Q4 24
-34.8%
Q3 24
-3.2%
-48.7%
Q2 24
-25.7%
-81.6%
Q1 24
-218.1%
-129.4%
EPS (diluted)
GPRO
GPRO
TARS
TARS
Q4 25
$-0.06
$-0.17
Q3 25
$-0.13
$-0.30
Q2 25
$-0.10
$-0.48
Q1 25
$-0.30
$-0.64
Q4 24
$-0.22
$-0.57
Q3 24
$-0.05
$-0.61
Q2 24
$-0.31
$-0.88
Q1 24
$-2.24
$-1.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GPRO
GPRO
TARS
TARS
Cash + ST InvestmentsLiquidity on hand
$49.7M
$417.3M
Total DebtLower is stronger
$44.3M
$72.4M
Stockholders' EquityBook value
$76.5M
$343.4M
Total Assets
$428.0M
$562.2M
Debt / EquityLower = less leverage
0.58×
0.21×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GPRO
GPRO
TARS
TARS
Q4 25
$49.7M
$417.3M
Q3 25
$152.8M
$401.8M
Q2 25
$58.6M
$381.1M
Q1 25
$69.6M
$407.9M
Q4 24
$102.8M
$291.4M
Q3 24
$130.2M
$317.0M
Q2 24
$133.0M
$323.6M
Q1 24
$133.7M
$298.5M
Total Debt
GPRO
GPRO
TARS
TARS
Q4 25
$44.3M
$72.4M
Q3 25
$43.9M
$72.3M
Q2 25
$72.1M
Q1 25
$72.0M
Q4 24
$0
$71.8M
Q3 24
$93.1M
$71.7M
Q2 24
$92.9M
$71.6M
Q1 24
$92.7M
$29.9M
Stockholders' Equity
GPRO
GPRO
TARS
TARS
Q4 25
$76.5M
$343.4M
Q3 25
$80.5M
$335.1M
Q2 25
$97.9M
$332.6M
Q1 25
$110.0M
$342.5M
Q4 24
$151.7M
$224.5M
Q3 24
$183.9M
$237.5M
Q2 24
$184.7M
$252.2M
Q1 24
$224.9M
$275.2M
Total Assets
GPRO
GPRO
TARS
TARS
Q4 25
$428.0M
$562.2M
Q3 25
$538.6M
$534.6M
Q2 25
$439.0M
$495.0M
Q1 25
$462.5M
$500.8M
Q4 24
$543.7M
$377.0M
Q3 24
$661.6M
$376.3M
Q2 24
$556.8M
$376.8M
Q1 24
$575.8M
$349.3M
Debt / Equity
GPRO
GPRO
TARS
TARS
Q4 25
0.58×
0.21×
Q3 25
0.55×
0.22×
Q2 25
0.22×
Q1 25
0.21×
Q4 24
0.00×
0.32×
Q3 24
0.51×
0.30×
Q2 24
0.50×
0.28×
Q1 24
0.41×
0.11×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GPRO
GPRO
TARS
TARS
Operating Cash FlowLast quarter
$15.6M
$19.3M
Free Cash FlowOCF − Capex
$15.0M
$13.0M
FCF MarginFCF / Revenue
7.4%
8.6%
Capex IntensityCapex / Revenue
0.3%
4.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-24.0M
$-22.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GPRO
GPRO
TARS
TARS
Q4 25
$15.6M
$19.3M
Q3 25
$12.2M
$18.3M
Q2 25
$8.8M
$-29.4M
Q1 25
$-57.2M
$-20.7M
Q4 24
$-25.1M
$-22.2M
Q3 24
$-2.2M
$-8.7M
Q2 24
$605.0K
$-14.4M
Q1 24
$-98.4M
$-37.8M
Free Cash Flow
GPRO
GPRO
TARS
TARS
Q4 25
$15.0M
$13.0M
Q3 25
$11.2M
$16.3M
Q2 25
$8.3M
$-30.4M
Q1 25
$-58.5M
$-21.2M
Q4 24
$-25.5M
$-22.3M
Q3 24
$-4.2M
$-8.9M
Q2 24
$-111.0K
$-15.4M
Q1 24
$-99.4M
$-38.0M
FCF Margin
GPRO
GPRO
TARS
TARS
Q4 25
7.4%
8.6%
Q3 25
6.9%
13.8%
Q2 25
5.4%
-29.6%
Q1 25
-43.5%
-27.1%
Q4 24
-12.7%
-33.5%
Q3 24
-1.6%
-18.6%
Q2 24
-0.1%
-37.8%
Q1 24
-63.9%
-137.5%
Capex Intensity
GPRO
GPRO
TARS
TARS
Q4 25
0.3%
4.2%
Q3 25
0.6%
1.6%
Q2 25
0.3%
1.0%
Q1 25
1.0%
0.8%
Q4 24
0.2%
0.1%
Q3 24
0.8%
0.6%
Q2 24
0.4%
2.5%
Q1 24
0.6%
0.6%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GPRO
GPRO

Subscription And Services$106.3M53%
Other$95.4M47%

TARS
TARS

Segment breakdown not available.

Related Comparisons